Financial Modeling for Pharma Stock Analysis

Evaluating pharmaceutical companies requires a specialized approach due to complex drug pipelines, patent lifecycles, and regulatory approval risks. This text-based course guides you through the foundational concepts of pharmaceutical financial modeling, helping you translate scientific potential into structured financial forecasts. You will transition from understanding basic financial statements to constructing valuation models tailored specifically to the pharma sector. Through clear written explanations and step-by-step modeling exercises, you will gain the skills needed to analyze healthcare stocks with confidence. What you'll learn: Understand foundational pharmaceutical industry metrics, patent cliffs, and drug development phases; Project revenues based on drug pipeline success probabilities and market penetration rates; Build risk-adjusted Net Present Value (rNPV) models for clinical assets; Analyze historical financial statements of pharmaceutical companies to establish forecasting baselines; Apply modern scenario analysis to model clinical trial outcomes; Calculate target stock prices using discounted cash flow (DCF) and relative valuation multiples. The course begins with essential industry terminology and regulatory frameworks before guiding you through revenue forecasting, pipeline probability modeling, and final valuation techniques. You will practice these concepts through comprehensive written scenarios and step-by-step calculations. This course is designed for beginner financial analysts, students, and retail investors who want to specialize in the healthcare sector, with no prior experience in pharmaceutical analysis required. Start your journey into pharmaceutical equity research today.